Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 535 M551 M595 M627 M690 M 2.46 B Research & development ————— — Operating income 394 M511 M552 M424 M581 M 2.07 B Non-Operating Income, Total 122 M-60 M-154 M-2.16 B-41 M -2.41 B Interest expense, net of interest capitalized 139 M143 M125 M98 M99 M 465 M Non-Operating Income, excl. Interest Expenses -139 M-143 M-125 M-98 M-99 M -465 M Unusual income/expense 122 M-60 M-154 M-2.16 B-41 M -2.41 B Pretax income 375 M308 M259 M-1.83 B441 M -824 M Equity in earnings ————— — Taxes 2 M0-4 M-2.78 B36 M -2.75 B Non-controlling/minority interest 157 M125 M112 M94 M155 M 486 M After tax other income/expense ————— — Net income before discontinued operations 216 M183 M151 M857 M250 M 1.44 B Discontinued operations ————— — Net income 216 M183 M151 M857 M250 M 1.44 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 216 M183 M151 M1.34 B250 M 1.93 B Basic earnings per share (Basic EPS) 0.320.270.221.240.35 2.07 Diluted earnings per share (Diluted EPS) 0.30.260.210.930.34 1.73 Average basic shares outstanding 670.29 M673.7 M681.24 M688.17 M713.75 M — Diluted shares outstanding 712.93 M714.62 M720.5 M1.12 B740.42 M — EBITDA 390 M508 M553 M425 M581 M 2.07 B EBIT 360 M480 M523 M381 M553 M 1.94 B Cost of revenue 3.3 B3.78 B4.5 B4.55 B5.16 B 17.99 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 30 M28 M30 M44 M28 M 130 M